FINANCIAL PRODUCTS
FACT SHEET
|
|
Offering Period: October 31, 2013 – November 21, 2013
5½ Year Digital-Plus Barrier Notes Linked to the S&P 500
®
Index
Additional Risk Considerations
|
•
|
|
Prior to maturity, costs such as concessions and hedging may affect the value of the
securities.
|
|
•
|
|
The securities will be affected by a number of economic, financial, political, regulatory,
and judicial factors that may either offset or magnify each other.
|
|
•
|
|
Liquidity – The securities will not be listed on any securities exchange. Credit
Suisse (or its affiliates) intends to offer to purchase the securities in the secondary market but is not required to do so. Many
factors, most of which are beyond the control of the Issuer, will influence the value of the securities and the price at which
the securities may be purchased or sold in the secondary market. For example, the creditworthiness of the Issuer, including actual
or anticipated downgrades to the Issuer’s credit ratings, may be a contributing factor.
|
|
•
|
|
Potential Conflicts – We and our affiliates play a variety of roles in connection
with the issuance of the securities including acting as calculation agent, hedging our obligations under the securities and determining
the estimated value of the securities. The agent for this offering, Credit Suisse Securities (USA) LLC (“CSSU”), is
our affiliate. In accordance with FINRA Rule 5121, CSSU may not make sales in this offering to any discretionary account without
prior written approval of the customer.
|
|
•
|
|
As a holder of the securities, you will not have voting rights or rights to receive
cash dividends or other distributions with respect to the equity securities comprising the Underlying.
|
The risks set forth in the section entitled
“Product Risks” on the preceding page and this section “Additional Risk Considerations” are only intended
as summaries of some of the risks relating to an investment in the securities. Prior to investing in the securities, you should,
in particular, review the “Product Risks” and “Additional Risk Considerations” sections herein, the “Selected
Risk Considerations” section in the pricing supplement, and the “Risk Factors” section of the product supplement,
which set forth risks related to an investment in the securities.
Disclaimer
IRS Circular 230 Disclosure: Credit Suisse and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used and
cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated with Credit Suisse of any of the matters address herein or for the purpose of avoiding U.S. tax-related penalties.
Investment suitability must be determined individually for each investor, and the financial instruments described herein may not be suitable for all investors. The products described herein should generally be held to maturity
as early sales could result in lower than anticipated returns. This information is not intended to provide and should not be relied upon as providing accounting, legal, regulatory or tax advice. Investors should consult with their own advisors as to
these matters.
This material is not a product of Credit Suisse Research Departments. Financial Products may involve a high degree of risk, and may be appropriate investments only for sophisticated investors who are capable of understanding
and assuming the risks involved. Credit Suisse and its affiliates may have positions (long or short), effect transactions or make markets in securities or financial instruments mentioned herein (or options with respect thereto), or provide advice or
loans to, or participate in the underwriting or restructuring of the obligations, issuers of the stocks comprising the applicable index, indices or fund mentioned herein. Credit Suisse is a member of FINRA, NYSE and SIPC. Clients should contact their
salespersons at, and execute transactions through, a Credit Suisse entity qualified in their home jurisdiction unless governing law permits otherwise.
You may revoke your offer to purchase the securities at any time prior to the time at which we accept such offer on the date the securities are priced. We reserve the right to change the terms of, or reject any offer to
purchase the securities prior to their issuance. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in
which case we may reject your offer to purchase.
This document is a summary of the terms of the securities and factors that you should consider before deciding to invest in the securities. Credit Suisse has filed a registration statement (including pricing supplement,
product supplement, underlying supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this offering summary relates. Before you invest, you should read this summary together with
the Preliminary Pricing Supplement dated November 4, 2013, Underlying Supplement dated July 29, 2013, Product Supplement No. T-I dated March 23, 2012, Prospectus Supplement dated March 23, 2012 and Prospectus dated March 23, 2012 to understand fully the
terms of the securities and other considerations that are important in making a decision about investing in the securities. You may get these documents without cost by visiting EDGAR on the SEC Web site at
www.sec.gov
. Alternatively,
Credit Suisse, any agent or any dealer participating in this offering will arrange to send you the pricing supplement, product supplement, underlying supplement, prospectus supplement and prospectus if you so request by calling toll-free 1 (800)
221-1037.
You may access the pricing supplement related to the offering summarized herein on the SEC website at:
http://www.sec.gov/Archives/edgar/data/1053092/000095010313006417/dp41734_424b2-t268a.htm
You may access the product supplement, underlying supplement, prospectus supplement and prospectus on the SEC website at
www.sec.gov
or by clicking on the hyperlinks to each of the respective documents
incorporated by reference in the pricing supplement.